Prelude Therapeutics Growth Metrics (2024-2025) | PRLD

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -42.83%-48.76%-51.95%
Assets (QoQ) -9.23%-12.07%-11.01%-19.52%-18.65%-17.55%
Capital Expenditures Growth (1y) -83.74%-94.43%
Capital Expenditures (QoQ) 24.22%-82.45%-15.87%-11.32%-57.45%
Cash & Equivalents Growth (1y) 258.60%142.53%283.45%
Cash & Equivalents (QoQ) 10.86%-52.38%8.83%524.17%-25.02%-24.71%
Cash from Investing Activities Growth (1y) 99.18%-55.89%273.53%
Cash from Investing Activities (QoQ) -16.34%-58.91%106.07%181.16%-81.47%247.98%
Cash from Operations Growth (1y) -7.68%-13.09%29.97%
Cash from Operations (QoQ) 27.47%-18.38%24.00%-65.02%23.83%26.69%
EBITDA Margin Growth (1y) 75,705.00
EBITDA Margin (QoQ) 33,889.00
EBIT Growth (1y) 40.60%
EBIT Margin Growth (1y) 83,174.00
EBIT Margin (QoQ) 30,009.00
EBIT (QoQ) 1.59%
EBT Growth (1y) 40.60%
EBT Margin Growth (1y) 83,174.00
EBT Margin (QoQ) 30,009.00
EBT (QoQ) 1.59%
Enterprise Value Growth (1y) -319.93%-411.36%136.28%
Enterprise Value (QoQ) -53.28%-272.36%-54.19%-77.14%33.86%120.08%
EPS (Basic) Growth (1y) 39.53%
EPS (Basic) (QoQ) 11.63%
EPS (Weighted Average and Diluted) Growth (1y) 39.53%
EPS (Weighted Average and Diluted) (QoQ) 11.63%
FCF Margin Growth (1y) 61,789.00
FCF Margin (QoQ) 39,204.00
Free Cash Flow Growth (1y) -6.85%-11.44%30.13%
Free Cash Flow (QoQ) 27.01%-16.84%23.98%-64.82%23.87%26.75%
Net Cash Flow Growth (1y) 4,859.42%-565.14%225.62%
Net Cash Flow (QoQ) 634.42%-634.89%108.03%1,974.25%-152.23%244.46%
Net Income Growth (1y) 40.60%
Net Income (QoQ) 1.59%
Net Income towards Common Stockholders Growth (1y) 40.60%
Net Income towards Common Stockholders (QoQ) 1.59%
Net Margin Growth (1y) 83,174.00
Net Margin (QoQ) 30,009.00
Operating Income Growth (1y) 40.60%
Operating Income (QoQ) 1.59%
Operating Margin Growth (1y) 83,174.00
Operating Margin (QoQ) 30,009.00
Profit After Tax Growth (1y) 38.88%
Profit After Tax (QoQ) 10.97%
Property, Plant & Equipment (Net) Growth (1y) -12.42%-21.15%-23.20%
Property, Plant & Equipment (Net) (QoQ) 3.56%-4.66%-6.04%-5.60%-6.76%-7.14%
Revenue Growth (1y) 116.67%
Revenue (QoQ) 33.33%
Share-based Compensation Growth (1y) -30.92%-37.45%-59.11%
Share-based Compensation (QoQ) 9.93%-2.82%-36.31%1.54%-0.47%-36.47%
Shareholder's Equity Growth (1y) -51.04%-58.39%-62.58%
Shareholder's Equity (QoQ) -13.50%-14.18%-15.96%-21.51%-26.50%-22.82%